- Report
- May 2026
- 150 Pages
Global
From €2438EUR$2,699USD£2,089GBP
- Report
- January 2026
- 200 Pages
Global
From €4511EUR$4,995USD£3,865GBP
- Report
- April 2026
- 160 Pages
Global
From €2998EUR$3,320USD£2,569GBP
€3748EUR$4,150USD£3,211GBP
- Report
- August 2025
- 189 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- January 2025
- 180 Pages
Global
From €4064EUR$4,500USD£3,482GBP
- Report
- May 2026
- 150 Pages
United Kingdom
From €4380EUR$4,850USD£3,753GBP
- Report
- May 2026
- 150 Pages
Germany
From €4380EUR$4,850USD£3,753GBP
- Report
- May 2026
- 150 Pages
India
From €4380EUR$4,850USD£3,753GBP
- Report
- December 2023
- 180 Pages
Global
From €2258EUR$2,500USD£1,935GBP
The Fungal Infection Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of infectious diseases caused by bacteria, viruses, fungi, and parasites. Fungal Infection Drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common fungal infections include athlete's foot, ringworm, and yeast infections.
Fungal Infection Drugs are available in a variety of forms, including tablets, capsules, creams, and ointments. These drugs are typically prescribed by a doctor and can be purchased over-the-counter or online.
Some companies in the Fungal Infection Drug market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Bayer. Show Less Read more
